Navigation Links
Surviving Mesothelioma Examines the Future of the Mesothelioma Drug Whose Clinical Trial Was Stopped Early This Week
Date:9/30/2015

Although a clinical trial of defactinib (VS-6063) for mesothelioma was shut down this week because of “futility”, the jury is still out on whether the drug may work better in combination than by itself. Surviving Mesothelioma has more on the company’s plans for defactinib. Click here to read the full article.

Verastem, the makers of the FAK-inhibitor defactinib, said in a statement that the trial of the drug as a single agent for mesothelioma was not having enough impact to justify its continuation.

“With the aggressiveness of this disease, the use of single agent VS-6063 as a maintenance treatment following chemotherapy where all patients had residual disease was not sufficient,” explains Verastem Chief Medical Officer Lou Vaickus, MD.

But another mesothelioma trial that pairs defactinib with an FAK-inhibitor called VS-5584 is still recruiting patients and the company says there is evidence that the two agents may work “synergistically” to fight mesothelioma.

“Although this particular drug does not appear to prevent mesothelioma relapse by itself, it should be encouraging for patients and families to know that other similar drugs and drug combinations are still in the pipeline,” says Surviving Mesothelioma Managing Editor Alex Strauss.

For more on this week’s announcement and a better understanding of how FAK-inhibitors like defactinib are thought to work against mesothelioma, see Scrubbed Trial May Not Be the End for Mesothelioma Drug, now available on the Surviving Mesothelioma website.

“Verastem Stops Enrollment Due to Futility in the COMMAND Study of VS-6063 for the Treatment of Malignant Pleural Mesothelioma”, Company Statement, Verastem website, September 28, 2015, http://phx.corporate-ir.net/phoenix.zhtml?c=250749&p=irol-newsArticle&ID=2090793

Read the full story at http://www.prweb.com/releases/2015/10/prweb12991891.htm.


'/>"/>
Source: PRWeb
Copyright©2015 Vocus, Inc.
All rights reserved

Related medicine news :

1. Patients and Advocates Raise Awareness for Deadly Preventable Cancer, According to Surviving Mesothelioma
2. Surviving Mesothelioma Shines a Spotlight on World’s Longest-Living Mesothelioma Survivor in Advance of Mesothelioma Awareness Day
3. Study Finds Combination Therapy Produces Long-Term Mesothelioma Survival in Small Group of Patients, According to Surviving Mesothelioma
4. New Study Finds Trimodal Treatment Approach for Mesothelioma Prolongs Survival, According to Surviving Mesothelioma
5. Doctors Highlight “Learning Curve” for Mesothelioma Surgery in New Report, According to Surviving Mesothelioma
6. Swiss Team Proposes Prognostic Score for Mesothelioma Surgical Candidates, According to Surviving Mesothelioma
7. New Study Appears to Validate the Safety of Mesothelioma Surgery for Older Patients, According to Surviving Mesothelioma
8. Researchers Say Mesothelioma Not the Only Cancer Linked with Asbestos Exposure, According to Surviving Mesothelioma
9. Top Mesothelioma Researchers Highlight Targeted Therapies in New Report, According to Surviving Mesothelioma
10. Surviving Mesothelioma Puts New Orphan Drug into Perspective in New Article
11. Scientists Say Enzymes May Influence Chemotherapy Response in Mesothelioma, According to Surviving Mesothelioma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/11/2019)... ... ... PracticeLink Live! Atlanta Physician Career Fair will take place Thursday, November 14, ... continue until 8:00 p.m. A free, optional seminar for job-seeking physicians, residents and fellows, ... Both the career fair and seminar are open to residents and fellows, as well ...
(Date:11/9/2019)... ... 08, 2019 , ... Mount Sinai Medical-Legal Partnership (MSMLP), an organization formed to ... free special education law and advocacy assistance to families and patients in need. The ... the work of contributions of Blaine (“Fin”) Fogg, who was a member of the ...
(Date:11/7/2019)... ... November 06, 2019 , ... An October 13 article ... United States. According to the article, while no U.S. state had an obesity rate ... over 20 percent obese. The article cites quite a few reasons for this rise, ...
(Date:11/7/2019)... Va. (PRWEB) , ... November 07, 2019 , ... Understanding ... – 3:00 p.m. EST, https://www.fdanews.com/understandudi , Are EU device and IV diagnostics ... to new EU device regulations —UDI — is ahead, and many device and diagnostics ...
(Date:11/6/2019)... ... November 06, 2019 , ... ... label nutritional bar and functional powder solutions, recently achieved FSSC 22000 Certification of ... “We are pleased to share the news that we have achieved FSSC 22000 ...
Breaking Medicine News(10 mins):
(Date:11/6/2019)... ... ... Big Buzz continues to build upon a record year in 2019, significantly increasing ... - which primarily serves the biosciences, specialty clinic and senior living industries - was ... In June, Big Buzz was named a Top Colorado Agency with a 5.0 rating ...
(Date:11/6/2019)... VEGAS (PRWEB) , ... November 06, 2019 , ... ... program focused on sustainable results, today unveiled new research exploring mobile behaviors that ... weight loss program. , Presented at ObesityWeek 2019, the new study, “Mobile ...
(Date:11/5/2019)... SEATTLE (PRWEB) , ... November 05, 2019 , ... Ida ... a skilled nursing facility. This will result in the layoff of 147 full- and ... next 60 days. This transition will enable Ida Culver House Broadview to shift its ...
Breaking Medicine Technology: